| Product Code: ETC9551056 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Sweden Cell And Gene Therapy CDMO Market Overview |
3.1 Sweden Country Macro Economic Indicators |
3.2 Sweden Cell And Gene Therapy CDMO Market Revenues & Volume, 2021 & 2031F |
3.3 Sweden Cell And Gene Therapy CDMO Market - Industry Life Cycle |
3.4 Sweden Cell And Gene Therapy CDMO Market - Porter's Five Forces |
3.5 Sweden Cell And Gene Therapy CDMO Market Revenues & Volume Share, By Phase, 2021 & 2031F |
3.6 Sweden Cell And Gene Therapy CDMO Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.7 Sweden Cell And Gene Therapy CDMO Market Revenues & Volume Share, By Indication, 2021 & 2031F |
4 Sweden Cell And Gene Therapy CDMO Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing investments in research and development for cell and gene therapies in Sweden |
4.2.2 Favorable government regulations supporting the growth of the cell and gene therapy CDMO market |
4.2.3 Growing adoption of personalized medicine driving the demand for cell and gene therapy services |
4.3 Market Restraints |
4.3.1 High cost associated with cell and gene therapy development and manufacturing |
4.3.2 Complex regulatory requirements and approval processes for cell and gene therapy products in Sweden |
5 Sweden Cell And Gene Therapy CDMO Market Trends |
6 Sweden Cell And Gene Therapy CDMO Market, By Types |
6.1 Sweden Cell And Gene Therapy CDMO Market, By Phase |
6.1.1 Overview and Analysis |
6.1.2 Sweden Cell And Gene Therapy CDMO Market Revenues & Volume, By Phase, 2021- 2031F |
6.1.3 Sweden Cell And Gene Therapy CDMO Market Revenues & Volume, By Pre-clinical, 2021- 2031F |
6.1.4 Sweden Cell And Gene Therapy CDMO Market Revenues & Volume, By Clinical, 2021- 2031F |
6.2 Sweden Cell And Gene Therapy CDMO Market, By Product Type |
6.2.1 Overview and Analysis |
6.2.2 Sweden Cell And Gene Therapy CDMO Market Revenues & Volume, By Gene Therapy, 2021- 2031F |
6.2.3 Sweden Cell And Gene Therapy CDMO Market Revenues & Volume, By Gene-Modified Cell Therapy, 2021- 2031F |
6.2.4 Sweden Cell And Gene Therapy CDMO Market Revenues & Volume, By Cell Therapy, 2021- 2031F |
6.3 Sweden Cell And Gene Therapy CDMO Market, By Indication |
6.3.1 Overview and Analysis |
6.3.2 Sweden Cell And Gene Therapy CDMO Market Revenues & Volume, By Oncology, 2021- 2031F |
6.3.3 Sweden Cell And Gene Therapy CDMO Market Revenues & Volume, By Infectious Diseases, 2021- 2031F |
6.3.4 Sweden Cell And Gene Therapy CDMO Market Revenues & Volume, By Neurological disorders, 2021- 2031F |
6.3.5 Sweden Cell And Gene Therapy CDMO Market Revenues & Volume, By Rare Diseases, 2021- 2031F |
6.3.6 Sweden Cell And Gene Therapy CDMO Market Revenues & Volume, By Others, 2021- 2031F |
7 Sweden Cell And Gene Therapy CDMO Market Import-Export Trade Statistics |
7.1 Sweden Cell And Gene Therapy CDMO Market Export to Major Countries |
7.2 Sweden Cell And Gene Therapy CDMO Market Imports from Major Countries |
8 Sweden Cell And Gene Therapy CDMO Market Key Performance Indicators |
8.1 Number of clinical trials for cell and gene therapies conducted in Sweden |
8.2 Investment inflow in cell and gene therapy companies in Sweden |
8.3 Number of partnerships and collaborations between CDMOs and biopharmaceutical companies in Sweden |
9 Sweden Cell And Gene Therapy CDMO Market - Opportunity Assessment |
9.1 Sweden Cell And Gene Therapy CDMO Market Opportunity Assessment, By Phase, 2021 & 2031F |
9.2 Sweden Cell And Gene Therapy CDMO Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.3 Sweden Cell And Gene Therapy CDMO Market Opportunity Assessment, By Indication, 2021 & 2031F |
10 Sweden Cell And Gene Therapy CDMO Market - Competitive Landscape |
10.1 Sweden Cell And Gene Therapy CDMO Market Revenue Share, By Companies, 2024 |
10.2 Sweden Cell And Gene Therapy CDMO Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here